Family Report for: Plasmodium_subtelomeric_PST-A Plasmodium_subtelomeric_PST-A
Relationship
Comment
These proteins represent a paralogous family of genes found in Plasmodium falciparum and Plasmodium yoelii that are closely related to various phospholipases and lysophospholipases of plants as well as generally being related to the alpha/beta-fold superfamily of hydrolases. These genes are preferentially located in the subtelomeric regions of the chromosomes of both P. falciparum and P. yoelii. TIGRFAMs TIGR01607 (PST-A). Close sequences of other Apicomplexa species were included
Database
Sequences
Interpro
| IPR006494 (Plasmodium subtelomeric PST-A PST_A)
PIRSF
|
Pdoc
|
PFam
| Prints
|
Prosite
|
no EC number
Reference
Title: The Antimalarial Natural Product Salinipostin A Identifies Essential alpha/beta Serine Hydrolases Involved in Lipid Metabolism in P. falciparum Parasites
Yoo E , Schulze CJ , Stokes BH , Onguka O , Yeo T , Mok S , Gnadig NF , Zhou Y , Kurita K and Bogyo M <11 more author(s)>
Yoo E , Schulze CJ , Stokes BH , Onguka O , Yeo T , Mok S , Gnadig NF , Zhou Y , Kurita K , Foe IT , Terrell SM , Boucher MJ , Cieplak P , Kumpornsin K , Lee MCS , Linington RG , Long JZ , Uhlemann AC , Weerapana E , Fidock DA , Bogyo M (- 11)
Ref: Cell Chemical Biology, 27 :143, 2020 : PubMed Abstract ESTHER: Yoo_2020_Cell.Chem.Biol_27_143 PubMedSearch: Yoo 2020 Cell.Chem.Biol 27 143 PubMedID: 31978322 Gene_locus related to this paper: plaf7-q8ii19 ,
plafa-a0a143zya4 ,
plaf7-q8iik5 ,
plafa-MAL8P1.38 ,
plafa-PF07.0040 ,
plafa-PF10.0020 ,
plafa-PF10.0379 ,
plafa-PF13.0153 Inhibitor(s) related to this paper: MJN110 ,
JW651 ,
KML29 ,
Sal-A-alkyne ,
Salinipostin-A ,
Orlistat Abstract
Salinipostin A (Sal A) is a potent antiplasmodial marine natural product with an undefined mechanism of action. Using a Sal A-derived activity-based probe, we identify its targets in the Plasmodium falciparum parasite. All of the identified proteins contain alpha/beta serine hydrolase domains and several are essential for parasite growth. One of the essential targets displays a high degree of homology to human monoacylglycerol lipase (MAGL) and is able to process lipid esters including a MAGL acylglyceride substrate. This Sal A target is inhibited by the anti-obesity drug Orlistat, which disrupts lipid metabolism. Resistance selections yielded parasites that showed only minor reductions in sensitivity and that acquired mutations in a PRELI domain-containing protein linked to drug resistance in Toxoplasma gondii. This inability to evolve efficient resistance mechanisms combined with the non-essentiality of human homologs makes the serine hydrolases identified here promising antimalarial targets.
         Other Papers
No structure scheme yet for this family
No Structure yet in this family
Genes Proteins in Plasmodium_subtelomeric_PST-A family
(56)
Fragments of genes in Plasmodium_subtelomeric_PST-A family
(3)
Substrates of some enzymes in the Plasmodium_subtelomeric_PST-A family
(3)
Substrate Chemical_Nomenclature Protein
4-methylumbelliferyl-caprylate (4-methyl-2-oxochromen-7-yl) octanoate bactc-lipas
4-methylumbelliferyl-caprylate (4-methyl-2-oxochromen-7-yl) octanoate plafa-PF10.0379
Arachidonoyl-1-thioglycerol S-(2,3-dihydroxypropyl) (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenethioate human-MGLL
Arachidonoyl-1-thioglycerol S-(2,3-dihydroxypropyl) (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenethioate plafa-PF10.0379
Fosinopril (2S,4S)-4-cyclohexyl-1-[2-[[(1S)-2-methyl-1-propanoyloxypropoxy]-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid 9apic-BdFE1
Fosinopril (2S,4S)-4-cyclohexyl-1-[2-[[(1S)-2-methyl-1-propanoyloxypropoxy]-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid human-CES1
Inhibitors of some enzymes in the Plasmodium_subtelomeric_PST-A family
(6)
Inhibitor Chemical_Nomenclature Protein
JW651 1,1,1,3,3,3-Hexafluoropropan-2-yl 4-(bis(4-chlorophenyl)methyl)piperazine-1-carboxylate human-MGLL
JW651 1,1,1,3,3,3-Hexafluoropropan-2-yl 4-(bis(4-chlorophenyl)methyl)piperazine-1-carboxylate plafa-PF10.0379
KML29 1,1,1,3,3,3-hexafluoropropan-2-yl 4-[bis(1,3-benzodioxol-5-yl)-hydroxymethyl]piperidine-1-carboxylate human-MGLL
KML29 1,1,1,3,3,3-hexafluoropropan-2-yl 4-[bis(1,3-benzodioxol-5-yl)-hydroxymethyl]piperidine-1-carboxylate plafa-PF10.0379
MJN110 (2,5-dioxopyrrolidin-1-yl) 4-[bis(4-chlorophenyl)methyl]piperazine-1-carboxylate human-MGLL
MJN110 (2,5-dioxopyrrolidin-1-yl) 4-[bis(4-chlorophenyl)methyl]piperazine-1-carboxylate plafa-PF10.0379
Orlistat [(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate human-DAGLA
Orlistat [(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate human-DAGLB
Orlistat [(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate human-PNLIP
Orlistat [(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate human-FASN
Orlistat [(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate mycs2-a0r619
Orlistat [(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate human-PNLIPRP2
Orlistat [(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate human-ABHD16A
Orlistat [(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate myctu-a85c
Orlistat [(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate myctu-Rv3822
Orlistat [(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate plafa-PF10.0379
Orlistat [(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate staau-lipas
Orlistat [(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate human-CES2
Sal-A-alkyne plafa-PF10.0020
Sal-A-alkyne plafa-PF07.0040
Sal-A-alkyne plafa-a0a143zya4
Sal-A-alkyne plafa-PF10.0379
Sal-A-alkyne plafa-PF13.0153
Sal-A-alkyne plaf7-q8iik5
Sal-A-alkyne plaf7-q8ii19
Sal-A-alkyne plafa-MAL8P1.138
Salinipostin-A (3R,8aS)-5-butyl-3-oxo-3-pentadecoxy-8,8a-dihydro-1H-furo[3,4-e][1,3,2]dioxaphosphepin-6-one plafa-PF10.0020
Salinipostin-A (3R,8aS)-5-butyl-3-oxo-3-pentadecoxy-8,8a-dihydro-1H-furo[3,4-e][1,3,2]dioxaphosphepin-6-one plafa-PF07.0040
Salinipostin-A (3R,8aS)-5-butyl-3-oxo-3-pentadecoxy-8,8a-dihydro-1H-furo[3,4-e][1,3,2]dioxaphosphepin-6-one plafa-a0a143zya4
Salinipostin-A (3R,8aS)-5-butyl-3-oxo-3-pentadecoxy-8,8a-dihydro-1H-furo[3,4-e][1,3,2]dioxaphosphepin-6-one plafa-PF10.0379
Salinipostin-A (3R,8aS)-5-butyl-3-oxo-3-pentadecoxy-8,8a-dihydro-1H-furo[3,4-e][1,3,2]dioxaphosphepin-6-one plafa-PF13.0153
Salinipostin-A (3R,8aS)-5-butyl-3-oxo-3-pentadecoxy-8,8a-dihydro-1H-furo[3,4-e][1,3,2]dioxaphosphepin-6-one plaf7-q8iik5
Salinipostin-A (3R,8aS)-5-butyl-3-oxo-3-pentadecoxy-8,8a-dihydro-1H-furo[3,4-e][1,3,2]dioxaphosphepin-6-one plaf7-q8ii19
Salinipostin-A (3R,8aS)-5-butyl-3-oxo-3-pentadecoxy-8,8a-dihydro-1H-furo[3,4-e][1,3,2]dioxaphosphepin-6-one plafa-MAL8P1.138